Non-surgical management of spinal cord injury (Q34581480)

3 August 2017

1 reference

title

Non-surgical management of spinal cord injury (English)

1 reference

3 August 2017

Jeffrey J Legos

1

1 reference

3 August 2017

Jonas J Gopez

series ordinal

2

1 reference

3 August 2017

William F Young

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Expert Opinion on Investigational Drugs

3 August 2017

14

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 August 2017

11

1 reference

3 August 2017

4

1 reference

3 August 2017

469-482

1 reference

Pathophysiology of spinal cord trauma

3 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Update on the pathophysiology and pathology of acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Acute spinal cord injury, part I: pathophysiologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

The experimental basis for early pharmacological intervention in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Apoptosis after traumatic human spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Management of cervical spinal cord trauma in Southern California

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Lipid antioxidants in acute central nervous system injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

The neuroprotective pharmacology of methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Consequences of high-dose steroid therapy for acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Acute spinal cord injury, part II: contemporary pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Prevention of ischemic spinal cord injury: comparative effects of magnesium sulfate and riluzole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Coadministration of methylprednisolone with hypertonic saline solution improves overall neurological function and survival rates in a chronic model of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Engines, accelerators, and brakes on functional spinal cord repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

AIT-082 is neuroprotective against kainate-induced neuronal injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

NT-3, but not BDNF, prevents atrophy and death of axotomized spinal cord projection neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Neurotrophin-3 prevents death of axotomized Clarke's nucleus neurons in adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Effects of pro-inflammatory cytokines in experimental spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Regulatory mechanisms in stem cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Human neural stem cells: isolation, expansion and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Neural stem cells and gene therapy: prospects for repairing the injured spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.4.469

Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1523/JNEUROSCI.18-04-01393.1998

Identifiers

DOI

10.1517/13543784.11.4.469

1 reference

3 August 2017

1 reference